CN112137929A - Novel cosmetic antiseptic composition - Google Patents
Novel cosmetic antiseptic composition Download PDFInfo
- Publication number
- CN112137929A CN112137929A CN202011076264.7A CN202011076264A CN112137929A CN 112137929 A CN112137929 A CN 112137929A CN 202011076264 A CN202011076264 A CN 202011076264A CN 112137929 A CN112137929 A CN 112137929A
- Authority
- CN
- China
- Prior art keywords
- extract
- obtaining
- solution
- rosemary
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 239000002537 cosmetic Substances 0.000 title claims abstract description 27
- 230000002421 anti-septic effect Effects 0.000 title abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 59
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 32
- 244000173853 Sanguisorba officinalis Species 0.000 claims abstract description 30
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 30
- 229940092258 rosemary extract Drugs 0.000 claims abstract description 26
- 235000020748 rosemary extract Nutrition 0.000 claims abstract description 26
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims abstract description 26
- 239000002904 solvent Substances 0.000 claims abstract description 16
- 239000009429 Ginkgo biloba extract Substances 0.000 claims abstract description 14
- 239000003906 humectant Substances 0.000 claims abstract description 14
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims description 39
- 239000000706 filtrate Substances 0.000 claims description 38
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 37
- 241000218628 Ginkgo Species 0.000 claims description 35
- 235000011201 Ginkgo Nutrition 0.000 claims description 35
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 32
- 239000003755 preservative agent Substances 0.000 claims description 29
- 230000002335 preservative effect Effects 0.000 claims description 27
- 238000000605 extraction Methods 0.000 claims description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 241000196324 Embryophyta Species 0.000 claims description 18
- 239000000725 suspension Substances 0.000 claims description 18
- 238000001179 sorption measurement Methods 0.000 claims description 17
- 239000003480 eluent Substances 0.000 claims description 16
- -1 polyoxyethylenes Polymers 0.000 claims description 16
- 239000011347 resin Substances 0.000 claims description 14
- 229920005989 resin Polymers 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 13
- 239000012535 impurity Substances 0.000 claims description 13
- 229910001220 stainless steel Inorganic materials 0.000 claims description 12
- 239000010935 stainless steel Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 10
- 238000007873 sieving Methods 0.000 claims description 10
- 238000002137 ultrasound extraction Methods 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 241000949731 Ulmus davidiana Species 0.000 claims description 8
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 7
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 7
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 7
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 6
- 239000004359 castor oil Substances 0.000 claims description 6
- 235000019438 castor oil Nutrition 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000002481 ethanol extraction Methods 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 6
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 6
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 6
- 150000005846 sugar alcohols Polymers 0.000 claims description 6
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229930182470 glycoside Natural products 0.000 claims description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 150000002191 fatty alcohols Chemical class 0.000 claims description 3
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 3
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 3
- 230000003020 moisturizing effect Effects 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 2
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 2
- YMTZCQOAGFRQHV-UHFFFAOYSA-N 3-methyl-4,5-dihydro-1,2-thiazole Chemical compound CC1=NSCC1 YMTZCQOAGFRQHV-UHFFFAOYSA-N 0.000 claims description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 239000004287 Dehydroacetic acid Substances 0.000 claims description 2
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical group OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 229940071120 dehydroacetate Drugs 0.000 claims description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 claims description 2
- 229940061632 dehydroacetic acid Drugs 0.000 claims description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 claims description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 claims description 2
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 claims description 2
- 229960001083 diazolidinylurea Drugs 0.000 claims description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 2
- 108700019599 monomethylolglycine Proteins 0.000 claims description 2
- 229960005323 phenoxyethanol Drugs 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 229940101011 sodium hydroxymethylglycinate Drugs 0.000 claims description 2
- CITBNDNUEPMTFC-UHFFFAOYSA-M sodium;2-(hydroxymethylamino)acetate Chemical compound [Na+].OCNCC([O-])=O CITBNDNUEPMTFC-UHFFFAOYSA-M 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 4
- 235000005206 Hibiscus Nutrition 0.000 abstract 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 238000000265 homogenisation Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930182486 flavonoid glycoside Natural products 0.000 description 2
- 150000007955 flavonoid glycosides Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 239000003848 thrombocyte activating factor antagonist Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241001499808 Allium atrorubens Species 0.000 description 1
- 244000016163 Allium sibiricum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241000218791 Ginkgoaceae Species 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010061876 Obstruction Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 229930190125 Sanguisorbin Natural products 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241001106462 Ulmus Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000874 microwave-assisted extraction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 229940072113 onion extract Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 150000008505 β-D-glucopyranosides Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a novel cosmetic antiseptic composition, which relates to the field of antiseptic preparation and comprises the following components in parts by weight: the composition comprises, by weight, 1-8 parts of a ginkgo leaf extract, 0.5-8 parts of a rosemary extract, 0.5-17.5 parts of a sanguisorba extract, 0.5-11.5 parts of a cotton rose hibiscus leaf extract, 4.5-23.5 parts of a solubilizer, 8-50 parts of a humectant and 10-50 parts of water.
Description
Technical Field
The invention relates to the field of preservative preparation, and particularly relates to a novel cosmetic preservative composition.
Background
Preservatives are a class of food additives that inhibit microbial activity and prevent spoilage of products. To preserve the product for a certain period of time, measures must be taken to prevent microbial infection and proliferation. The use of preservatives has proven to be one of the most economical, effective and straightforward ways to achieve the above objectives.
The existing preservatives are generally divided into two categories, one is a chemical preservative and the other is a natural preservative. Chemical preservatives generally suffer from varying degrees of contamination and low toxicity. The natural preservative has the defects of narrow antibacterial spectrum, high price, peculiar smell and variegated colors. Therefore, the development of a safe, mild and efficient preservative system from natural plants as a substitute for chemical preservatives is a research hotspot in the field of cosmetic preservation at present. The natural plant-derived preservative takes bacteriostatic active ingredients extracted from natural plants as main active ingredients, and at present, natural plant preservatives on the market are rare, and have the problems of large taste, reduction of product influence on stability and the like.
Disclosure of Invention
According to the defects of the prior art, the invention aims to provide a novel cosmetic preservative composition which has a good bacteriostatic action on common microorganisms in cosmetics and has the characteristics of low skin irritation, safety and mildness.
The novel cosmetic preservative composition comprises the following components in parts by weight:
1-8 parts of ginkgo leaf extract, 0.5-8 parts of rosemary extract, 0.5-17.5 parts of garden burnet extract, 0.5-11.5 parts of cotton rose leaf extract, 4.5-23.5 parts of solubilizer, 8-50 parts of humectant and 10-50 parts of water.
Optionally, the humectant comprises a polyhydric alcohol comprising a combination of one or more of ethylhexylglycerin, caprylyl glycol, 1, 2-propanediol, 1, 2-pentanediol, or 1, 2-hexanediol.
Optionally, the humectant comprises a combination of ethylhexyl glycerin and caprylyl glycol, or a combination of 1, 2-pentanediol and 1, 2-hexanediol.
Optionally, the solubilizer is one or a combination of more of sorbitan, polyoxyethylene, alkanol polyether, fatty alcohol polyoxyethylene ether, POE castor oil or hydrogenated castor oil derivatives, fatty acid esters, sucrose fatty acid esters or alkyl glycoside.
Optionally, the paint also comprises a component A and a component B, wherein the weight part of the component A is 5-15 parts, and the weight part of the component B is 3-5 parts.
Optionally, the component A is one or more of imidazolidinyl urea, diazolidinyl urea, sodium hydroxymethyl glycinate, methylchloroisothiazolinone, methylisothiazoline, phenoxyethanol, ethylhexyl glycerol, caprylyl hydroximic acid, benzoic acid, sodium benzoate, dehydroacetic acid and dehydroacetate;
the component B is a composition of 1, 5-pentanediol and p-hydroxyacetophenone.
Optionally, the ginkgo biloba extract is prepared by the following steps:
removing impurities from the dried folium Ginkgo, pulverizing with a plant pulverizer, and sieving with a 40 mesh stainless steel mesh sieve to obtain folium Ginkgo powder;
obtaining ginkgo leaf powder, adding the ginkgo leaf powder into an ethanol extraction solvent with the concentration of 75% at normal temperature to obtain a ginkgo leaf extracting solution;
obtaining folium Ginkgo extractive solution, and performing ultrasonic filtration of folium Ginkgo extractive solution at 40-60 deg.C in ultrasonic instrument to obtain folium Ginkgo filtrate;
and (3) obtaining ginkgo leaf filtrate, carrying out vacuum concentration on the ginkgo leaf filtrate, and drying to obtain the ginkgo leaf extract.
Optionally, the rosemary extract is prepared by the following steps:
removing impurities from the dried rosemary, crushing the rosemary by using a plant crusher, and sieving the crushed rosemary through a 40-mesh stainless steel mesh sieve to obtain rosemary powder;
obtaining rosemary powder, and adding the rosemary powder into an ethanol extraction solvent with the concentration of 90% at normal temperature to obtain rosemary extract;
obtaining rosemary extract, and performing ultrasonic filtration on the rosemary extract in an ultrasonic instrument at the temperature of 45-50 ℃ to obtain rosemary filtrate;
obtaining rosemary filtrate, carrying out vacuum concentration on the rosemary filtrate, and drying to obtain a rosemary extract, wherein the rosemary extract is a fat-soluble extract.
Optionally, the sanguisorba officinalis extract is prepared by the following steps:
removing impurities from the dried roots of sanguisorba longicorna, crushing by using a plant crusher, and sieving by using a stainless steel mesh sieve of 40-80 meshes to obtain sanguisorba longicorna powder;
obtaining Ulmus davidiana var powder, adding Ulmus davidiana var powder into 85% ethanol water solution, and pretreating with low-temperature high-pressure homogenizer at 2-10 deg.C under 4-7MPa for 30s to obtain first extract;
obtaining a first extract, extracting by an ultrasonic-assisted extraction method at the material-liquid ratio of 1:20 and the extraction temperature of 30-45 ℃ for 0.5h, centrifuging and filtering after extraction, and collecting to obtain a first filtrate.
A first filtrate was taken and the filtrate was concentrated under reduced pressure to a volume of 1/5 which was the original volume to obtain a first concentrated suspension.
Obtaining a first concentrated suspension, and purifying the concentrated suspension through an adsorption resin to obtain a first eluent;
obtaining a first eluent, adding activated carbon for decoloring for 0.5h at the decoloring temperature of 40 ℃ to obtain a first decoloring solution;
and (3) obtaining a first destaining solution, carrying out reduced pressure concentration treatment on the first destaining solution to enable the volume of the first destaining solution to be concentrated to 1/7 of the original volume, and removing redundant ethanol to obtain a first concentrated solution.
Obtaining a first concentrated solution, and freeze-drying the first concentrated solution at-70-100 deg.C for 45 hr under vacuum pressure of 1.0Pa to obtain radix Sangusorbae extract.
Optionally, the cotton rose hibiscus leaf extract is prepared by the following steps:
removing impurities from the dried roots of the cotton rose hibiscus leaves, crushing by using a plant crusher, and sieving by using a stainless steel mesh sieve of 40-80 meshes to obtain cotton rose hibiscus leaf powder;
obtaining Hibiscus mutabilis leaf powder, adding the Hibiscus mutabilis leaf powder into 85% ethanol water solution, and pre-treating with a low-temperature high-pressure homogenizer at a homogenizing temperature of 2-10 deg.C, a homogenizing pressure of 4-7MPa, and a homogenizing time of 30s to obtain a second extract;
and (3) obtaining a second extract, extracting by adopting an ultrasonic-assisted extraction method, wherein the material-liquid ratio is 1:25, the extraction temperature is 30-45 ℃, the extraction time is 0.75h, centrifuging and filtering after extraction, and collecting to obtain a second filtrate.
And (3) obtaining a second filtrate, and concentrating the second filtrate under reduced pressure to obtain 1/5 with the volume being the original volume so as to obtain a second concentrated suspension.
Obtaining a second concentrated suspension, and purifying the second concentrated suspension through adsorption resin to obtain an eluent;
obtaining a second eluent, adding activated carbon for decoloring for 0.4h at the decoloring temperature of 45 ℃ to obtain a second decoloring solution;
and (3) obtaining a second destaining solution, carrying out reduced pressure concentration treatment on the second destaining solution to enable the volume of the second destaining solution to be concentrated to 1/8 of the original volume, and removing redundant ethanol to obtain a second concentrated solution.
Obtaining a second concentrated solution, adjusting the pH value to 10.5 by adopting a sodium hydroxide solution, centrifuging to remove precipitates, then adjusting the pH value to 4.5 by adopting a hydrochloric acid solution, and centrifuging to obtain precipitates to obtain a precipitate solution;
collecting precipitate, washing with deionized water, and freeze drying at-70-100 deg.C for 60 hr under vacuum pressure of 3.5Pa to obtain folium Hibisci Mutabilis extract.
The invention has the advantages that:
the ginkgo leaf extract, the rosemary extract, the sanguisorba officinalis extract and the cotton rose hibiscus leaf extract are combined to be used as active ingredients in the antiseptic composition to form a specific antiseptic combination, and the components are mutually synergistic, so that the obtained composition has a long-acting antiseptic effect, has a good broad-spectrum antibacterial effect, has a good bacteriostatic effect on common microorganisms in cosmetics, has the characteristics of low skin irritation, safety and mildness, is not easy to decay and deteriorate, and has low allergenicity.
Drawings
FIG. 1 is a schematic diagram of the preparation method of the present invention.
Detailed Description
In order to make the technical means, the creation characteristics, the achievement purposes and the effects of the invention easy to understand, the invention is further described with the specific embodiments.
As an embodiment of the invention, the invention provides a novel cosmetic preservative composition which comprises the following components in parts by weight:
1-8 parts of ginkgo leaf extract, 0.5-8 parts of rosemary extract, 0.5-17.5 parts of garden burnet extract, 0.5-11.5 parts of cotton rose leaf extract, 4.5-23.5 parts of solubilizer, 8-50 parts of humectant and 10-50 parts of water.
The anti-corrosion composition is designed by combining the ginkgo leaf extract, the rosemary extract, the sanguisorba extract and the cotton rose hibiscus leaf extract as active ingredients in the anti-corrosion composition to form a specific anti-corrosion combination, and the components are mutually synergistic, so that the obtained composition has a long-acting anti-corrosion effect, has a good broad-spectrum antibacterial effect, has a good antibacterial effect on common microorganisms in cosmetics, has the characteristics of low skin irritation, safety and mildness, is not easy to decay and deteriorate, and has low sensitization.
The preferred embodiments of the present invention will be described below with reference to the accompanying drawings.
The anticorrosive composition comprises the following components in parts by weight:
1-8 parts of ginkgo leaf extract, 0.5-8 parts of rosemary extract, 0.5-17.5 parts of garden burnet extract, 0.5-11.5 parts of cotton rose leaf extract, 4.5-23.5 parts of solubilizer, 8-50 parts of humectant and 10-50 parts of water.
Folium Ginkgo is dry leaf of Ginkgo biloba L of Ginkgoaceae. Collected in autumn when the leaves are still green, and dried in time. Generally, artificial cultivation is adopted. The cultivation areas are from north to Liaoning, from south to Guangdong, from east to Zhejiang, from west to Shaanxi, Gansu, from southwest to Sichuan, Guizhou, Yunnan and the like. Has the effects of promoting blood circulation, removing blood stasis, dredging collaterals, relieving pain, astringing lung, relieving asthma, eliminating turbid pathogen, and reducing blood lipid. Can be used for treating blood stasis, obstruction of collaterals, thoracic obstruction, cardialgia, apoplexy, hemiplegia, cough with asthma due to lung deficiency, and hyperlipidemia.
Ginkgo biloba leaves are still used by Chinese medicine for the treatment of memory loss, stomach pain, dysentery, hypertension, mental stress and respiratory problems such as asthma, bronchitis and poor circulation and anxiety caused by them. The active ingredient of ginkgo is the terpene fraction, which includes bilobalide and bilobalide. The ginkgetin-glycoside components have strong antioxidant and free radical scavenging capacity.
The ginkgo leaf extract has wide medicinal value and application. By adopting advanced technology, process and equipment, the pharmacological action is more obvious through further extraction, separation and purification, the PAF receptor antagonist has obvious antagonistic effect, and the PAF receptor antagonist can also play a role in the aspects of anti-inflammation, anti-allergy, blood vessel dilation, cardiovascular and cerebrovascular protection, peripheral blood circulation improvement, serum cholesterol reduction, auxiliary anticancer and the like, and can be widely applied to the prevention and the health care of cardiovascular and cerebrovascular diseases, nervous system diseases and the like.
Rosemary is a shrub of the genus Rosmarinus of the class Dicotyledoneae, the family Labiatae. Sexual pleasure with warm climates, native European regions and the coast of the Mediterranean region in the northern part of Africa. Antioxidant and rosemary essential oil having excellent antioxidant activity can be extracted from flowers and leaves of rosemary. Rosemary antioxidant. The product can be widely used for keeping the freshness and quality of medicines, fried foods, oil-rich foods and various oils; the rosemary essence is used in the daily chemical industries of spice, air freshener, ant repellent, sterilization, disinsection and the like.
The radix Sangusorbae is plant of Ulmus of Rosaceae. Perennial herbs with the height of 30-120cm and middle plants are common traditional Chinese medicines. According to the record of Chinese pharmacopoeia, sanguisorba is bitter, sour, astringent and slightly cold in taste and enters liver and large intestine channels; can be used for treating hematochezia, hemorrhoidal bleeding, bloody dysentery, metrorrhagia, scald due to hot water and fire, carbuncle, swelling, and sore.
The radix Sangusorbae extract contains abundant nutrients and physiologically active components, such as flavone components, saponin components, tannin components, steroid and its glycoside components, and saccharide components. The sanguisorba contains abundant saponins, contains a large amount of triterpenoid saponins such as sanguisorbin, polyglaucol 28 beta-D-glucopyranoside and garcinolic acid glucoside, and has good hemostatic, anti-tumor, antiallergic, anti-inflammatory and detumescence effects. Radix Sangusorbae has inhibitory effect on typhoid bacillus, meningococcus, and Shigella flexneri.
Folium Hibisci Mutabilis is derived from dry leaf of Hibisci Mutabilis of Malvaceae. According to the record of Chinese pharmacopoeia, the taste of the leaves of the cotton rose hibiscus is pungent and mild; entering lung and liver meridians; has effects in cooling blood, removing toxic materials, relieving swelling and pain; it can be used for treating carbuncle, cellulitis, swelling, scald, conjunctival congestion, swelling and pain, and traumatic injury. The major chemical components of the cotton rose hibiscus leaf comprise flavonoid glycoside, phenols, amino acids, tannin, reducing sugar, steroid compounds and volatile oil, wherein the flavonoid glycoside is the major active component. The flavonoid compound has good antioxidant and antibacterial effects. Preferably, the content of saponin in the cotton rose hibiscus leaf extract is increased, so that the preservative effect of the preservative composition can be improved, and the preservative effect is better when the content of total flavone in the cotton rose hibiscus leaf extract is not less than 88% of the total mass of the cotton rose hibiscus leaf extract.
In this embodiment, the humectant may be, for example, but not limited to, a polyhydric alcohol, a natural moisturizing factor, or an amino acid, and in some preferred embodiments, the humectant is preferably a polyhydric alcohol-based humectant including one or more of ethylhexylglycerin, caprylyl glycol, 1, 2-propylene glycol, 1, 2-pentanediol, or 1, 2-hexanediol. In this example, the humectant moisturizer comprises a combination of ethylhexyl glycerin and caprylyl glycol, or a combination of 1, 2-pentanediol and 1, 2-hexanediol. The solubilizer is one or more of sorbitan, polyoxyethylene, alkanol polyether, fatty alcohol polyoxyethylene ether, POE castor oil or hydrogenated castor oil derivative, fatty acid ester, sucrose fatty acid ester or alkyl glycoside.
The antiseptic composition has the characteristics of low irritation and high stability. The sanguisorba officinalis extract and the polyhydric alcohol serving as the humectant have a synergistic effect, have a certain moisturizing property while improving the preservative effect, have a remarkable antioxidation effect, and have a certain anti-aging effect while having the preservative effect. The anticorrosive effect of the anticorrosive composition can be further optimized by optimizing the selection of each raw material and the adjustment of the dosage of each raw material.
The preparation method of the anticorrosive composition comprises the following steps:
mixing extract of Allium scorodoprasum, extract of sanguisorba officinalis, extract of Hibiscus mutabilis leaf and optional adjuvants to obtain the antiseptic composition, and the method has the advantages of simple process and convenient operation. In some preferred embodiments, the preservative composition is obtained by dissolving an extract of red onion of the family iridaceae, an extract of sanguisorba officinalis and an extract of leaves of cotton rose hibiscus in a mixture of deionized water and a humectant, adding a solubilizer, mixing uniformly, and separating insoluble substances.
Referring to fig. 1, the method specifically includes the following steps: mixing deionized water and polyhydric alcohol, stirring and heating to 40-60 ℃;
s100) adding the ginkgo leaf onion extract, the rosemary extract, the sanguisorba extract and the cotton rose leaf extract, stirring and dissolving at the stirring speed of 300-;
s200) adding a solubilizer, uniformly stirring at the stirring speed of 300-600r/min, and keeping the temperature for 5-15 min;
s300) cooling to below 30 ℃, and filtering to obtain the anticorrosive composition.
The antiseptic composition has the advantage of wide application, can be applied to cosmetic products with various functions and forms, and can be applied to skin care products, color cosmetics or cosmeceuticals; the active ingredients of the antiseptic composition are natural ingredients, so that cosmetics using the antiseptic composition have the advantage of being not easy to decay and deteriorate, and have low sensitization. It is understood that the cosmetic may be, for example, but not limited to, a variety of skin care, color or cosmeceutical products to achieve cleansing, maintenance, beauty, embellishment and change appearance. In some alternative embodiments, the cosmetic product may be, for example, but not limited to, a skin cream, a skin lotion, a moisturizer, a skin essence, a face cleanser, or a mask.
In the antiseptic composition, the ginkgo biloba extract is prepared by the following steps:
s110) removing impurities from the dried ginkgo leaves, crushing the ginkgo leaves by using a plant crusher, and sieving the ginkgo leaves by using a 40-mesh stainless steel mesh sieve to obtain ginkgo leaf powder;
s210) obtaining ginkgo leaf powder, and adding the ginkgo leaf powder into an ethanol extraction solvent with the concentration of 75% at normal temperature to obtain a ginkgo leaf extracting solution;
s410) obtaining a ginkgo leaf extracting solution, and performing ultrasonic filtration on the ginkgo leaf extracting solution in an ultrasonic instrument at the temperature of 40-60 ℃ to obtain a ginkgo leaf filtrate;
s410) obtaining ginkgo leaf filtrate, carrying out vacuum concentration on the ginkgo leaf filtrate, and drying to obtain the ginkgo leaf extract.
In the preservative composition, the rosemary extract is prepared by the following steps:
s120) removing impurities from the dried rosemary, crushing the rosemary by using a plant crusher, and sieving the crushed rosemary by using a 40-mesh stainless steel mesh sieve to obtain rosemary powder;
s220) obtaining rosemary powder, and adding the rosemary powder into an ethanol extraction solvent with the concentration of 90% at normal temperature to obtain rosemary extract;
s320) obtaining a rosemary extract, and performing ultrasonic filtration on the rosemary extract in an ultrasonic instrument at the temperature of 45-50 ℃ to obtain rosemary filtrate;
s420) obtaining rosemary filtrate, concentrating the rosemary filtrate in vacuum, and drying to obtain a rosemary extract, wherein the rosemary extract is a fat-soluble extract.
In the antiseptic composition, the sanguisorba officinalis extract is prepared by the following steps:
s130) removing impurities from the dried roots of sanguisorba longicorna, crushing the roots by using a plant crusher, and screening the crushed roots by using a stainless steel screen of 40-80 meshes to obtain sanguisorba longicorna powder;
s230) obtaining ulmus davidiana var powder, adding the ulmus davidiana var powder into an ethanol water solution with the concentration of 85%, pretreating the ulmus davidiana var powder by using a low-temperature high-pressure homogenizer, and pretreating the ulmus davidiana var powder by using a low-temperature high-pressure homogenizer at the homogenization temperature of 4 ℃, the homogenization pressure of 5.5MPa and the homogenization time of 30S to obtain a first extract;
s330) obtaining a first extract, extracting by adopting an ultrasonic-assisted extraction method, wherein the ultrasonic power is 342W, the material-liquid ratio is 1:20, the extraction temperature is 40 ℃, the extraction time is 0.5h, centrifuging and filtering are carried out after extraction, and a first filtrate is collected and obtained.
S430) obtaining a first filtrate, and carrying out reduced pressure concentration treatment on the filtrate to ensure that the volume of the filtrate is concentrated to 1/5 of the original volume, so as to obtain a first concentrated suspension.
S530) obtaining a first concentrated suspension, purifying the concentrated suspension by using an adsorption resin, wherein an eluent is a 75% ethanol water solution, the elution amount is 1.5BV, and the elution speed is 1.5BV/h, so as to obtain a first eluent;
s630) obtaining a first eluent, adding activated carbon for decoloring, wherein the adding amount of the activated carbon is 0.5%, the decoloring time is 0.5h, and the decoloring temperature is 40 ℃, so as to obtain a first decoloring solution;
s730) obtaining a first destaining solution, carrying out reduced pressure concentration treatment on the first destaining solution to enable the volume of the first destaining solution to be concentrated to 1/7 of the original volume, and removing redundant ethanol to obtain a first concentrated solution.
S830) obtaining a first concentrated solution, and freeze-drying the first concentrated solution at-85 ℃ for 45h under the vacuum pressure of 1.0Pa to obtain the sanguisorba officinalis extract.
In the antiseptic composition, the cotton rose leaf extract is prepared by the following steps:
s140) removing impurities from the dried roots of the cotton rose hibiscus leaves, crushing the roots by using a plant crusher, and screening the crushed roots by using a stainless steel screen of 40-80 meshes to obtain cotton rose hibiscus leaf powder;
s240) obtaining cotton rose hibiscus leaf powder, adding the cotton rose hibiscus leaf powder into an ethanol water solution with the concentration of 85%, and pretreating the cotton rose hibiscus leaf powder by adopting a low-temperature high-pressure homogenizer, wherein the homogenization temperature is 4 ℃, the homogenization pressure is 5.5MPa, and the homogenization time is 30S, so as to obtain a second extract;
s340) obtaining a second extract, extracting by adopting an ultrasonic-assisted extraction method, wherein the ultrasonic power is 304W, the material-liquid ratio is 1:30, the extraction temperature is 35 ℃, the extraction time is 0.75h, centrifuging and filtering are carried out after extraction, and a second filtrate is collected and obtained.
S440) obtaining a second filtrate, and carrying out reduced pressure concentration treatment on the second filtrate to ensure that the volume of the second filtrate is concentrated to 1/5 of the original volume, so as to obtain a second concentrated suspension.
S540) obtaining a second concentrated suspension, purifying the second concentrated suspension by using adsorption resin, wherein the eluent is 90% ethanol, the elution amount is 3.0BV, and the elution flow rate is 2BV/h to obtain an eluent;
s640) obtaining a second eluent, adding activated carbon for decoloring, wherein the adding amount of the activated carbon is 0.5% of the solution mass, the decoloring temperature is 50 ℃, the decoloring time is 0.5h, the centrifugal speed is 4500r/min, and the centrifugal time is 30min, so that a second decoloring solution is obtained;
s740) obtaining a second destaining solution, carrying out reduced pressure concentration treatment on the second destaining solution to enable the volume of the second destaining solution to be concentrated to 1/8 of the original volume, and removing redundant ethanol to obtain a second concentrated solution.
S840) obtaining a second concentrated solution, adjusting the pH value to 10.5 by adopting a sodium hydroxide solution, centrifuging to remove precipitates, adjusting the pH value to 4.5 by adopting a hydrochloric acid solution, and centrifuging to obtain precipitates to obtain a precipitation solution;
s940) obtaining a precipitation solution, washing the precipitation solution with deionized water, and carrying out freeze drying at the freezing temperature of-90 ℃, for 60h, under the vacuum pressure of 3.5Pa, so as to obtain the cotton rose hibiscus leaf extract.
The low-temperature high-pressure homogenization technology is applied to the pretreatment of the garden burnet, so that the damage of the pretreatment to effective components can be avoided, the high-pressure homogenization can effectively promote the dissolution of target components, and compared with the prior art, the technology can effectively improve the extraction efficiency. The sanguisorba officinalis extract is purified by using an adsorption resin purification technology, so that the content of total saponins in the obtained sanguisorba officinalis extract can be improved, and interference components can be effectively separated.
The extraction method is water bath extraction, ultrasonic-assisted extraction or microwave extraction, preferably ultrasonic-assisted extraction. The sanguisorba officinalis is extracted by using an ultrasonic extraction technology, the extraction efficiency can be remarkably improved by the cavitation effect, the mechanical vibration effect and the heat effect of ultrasonic waves, and meanwhile, the extraction time is shortened and the damage of the extraction process to target components is reduced.
In some preferred embodiments, the process parameter for ultrasound-assisted extraction is the ultrasound power 228380W
The adsorption resin is macroporous adsorption resin, preferably weak polar or nonpolar macroporous adsorption resin; preferably, the model of the macroporous adsorption resin is HPD-100, D101, D4020 or PD-400. The macroporous adsorption resin can selectively adsorb saponin in sanguisorba officinalis, and can remove unstable components such as sugar, protein and part of pigments in the extract, thereby effectively improving the purity of the sanguisorba officinalis extract.
The eluent purified by the adsorption resin is decolorized, preferably by activated carbon, and the sanguisorba officinalis extract purified by the adsorption resin and decolorized by the activated carbon is light in color, so that the problem of dark color of the traditional plant extract is obviously improved. The dosage of the active carbon is preferably 0.2-2% of the mass of the eluent, the active carbon has no selectivity on the adsorption of system substances, the decoloring effect is poor due to too low dosage, the impurity adsorption is also affected, the dosage is too high, although the decoloring effect is good, the adsorption capacity is increased, more target components are adsorbed, and the loss of effective substances of the system is too large.
It will be appreciated by those skilled in the art that the invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. The embodiments disclosed above are therefore to be considered in all respects as illustrative and not restrictive. All changes which come within the scope of or equivalence to the invention are intended to be embraced therein.
Claims (10)
1. A novel cosmetic preservative composition is characterized by comprising the following components in parts by weight:
1-8 parts of ginkgo leaf extract, 0.5-8 parts of rosemary extract, 0.5-17.5 parts of garden burnet extract, 0.5-11.5 parts of cotton rose leaf extract, 4.5-23.5 parts of solubilizer, 8-50 parts of humectant and 10-50 parts of water.
2. A novel cosmetic preservative composition according to claim 1, characterized in that said humectant comprises a polyhydric alcohol comprising one or a combination of more of ethylhexylglycerin, caprylyl glycol, 1, 2-propanediol, 1, 2-pentanediol or 1, 2-hexanediol.
3. A novel cosmetic preservative composition according to claim 2, characterized in that said moisturizing agent comprises a combination of ethylhexyl glycerin and caprylyl glycol or a combination of 1, 2-pentanediol and 1, 2-hexanediol.
4. A novel cosmetic preservative composition according to claim 3, characterized in that said solubilizing agent is a combination of one or more of sorbitan, polyoxyethylenes, alkanol polyethers, fatty alcohol polyoxyethylene ethers, POE castor oil or hydrogenated castor oil derivatives, fatty acid esters, sucrose fatty acid esters or alkyl glycosides.
5. A novel cosmetic preservative composition according to claim 4, characterized by further comprising 5 to 15 parts by weight of component A and 3 to 5 parts by weight of component B.
6. A novel cosmetic preservative composition according to claim 5, characterized in that component A is a combination of one or more of imidazolidinyl urea, diazolidinyl urea, sodium hydroxymethylglycinate, methylchloroisothiazolinone, methylisothiazoline, phenoxyethanol, ethylhexylglycerin, caprylhydroxamic acid, benzoic acid, sodium benzoate, dehydroacetic acid, dehydroacetate;
the component B is a composition of 1, 5-pentanediol and p-hydroxyacetophenone.
7. The novel cosmetic preservative composition according to claim 6, wherein the ginkgo biloba extract is prepared by the following steps:
removing impurities from the dried folium Ginkgo, pulverizing with a plant pulverizer, and sieving with a 40 mesh stainless steel mesh sieve to obtain folium Ginkgo powder;
obtaining ginkgo leaf powder, adding the ginkgo leaf powder into an ethanol extraction solvent with the concentration of 75% at normal temperature to obtain a ginkgo leaf extracting solution;
obtaining folium Ginkgo extractive solution, and performing ultrasonic filtration of folium Ginkgo extractive solution at 40-60 deg.C in ultrasonic instrument to obtain folium Ginkgo filtrate;
and (3) obtaining ginkgo leaf filtrate, carrying out vacuum concentration on the ginkgo leaf filtrate, and drying to obtain the ginkgo leaf extract.
8. A novel cosmetic preservative composition according to claim 7, characterized in that said rosemary extract is prepared by the following steps:
removing impurities from the dried rosemary, crushing the rosemary by using a plant crusher, and sieving the crushed rosemary through a 40-mesh stainless steel mesh sieve to obtain rosemary powder;
obtaining rosemary powder, and adding the rosemary powder into an ethanol extraction solvent with the concentration of 90% at normal temperature to obtain rosemary extract;
obtaining rosemary extract, and performing ultrasonic filtration on the rosemary extract in an ultrasonic instrument at the temperature of 45-50 ℃ to obtain rosemary filtrate;
obtaining rosemary filtrate, carrying out vacuum concentration on the rosemary filtrate, and drying to obtain a rosemary extract, wherein the rosemary extract is a fat-soluble extract.
9. The novel cosmetic preservative composition according to claim 8, wherein the sanguisorba officinalis extract is prepared by the steps of:
removing impurities from the dried roots of sanguisorba longicorna, crushing by using a plant crusher, and sieving by using a stainless steel mesh sieve of 40-80 meshes to obtain sanguisorba longicorna powder;
obtaining Ulmus davidiana var powder, adding Ulmus davidiana var powder into 85% ethanol water solution, and pretreating with low-temperature high-pressure homogenizer at 2-10 deg.C under 4-7MPa for 30s to obtain first extract;
obtaining a first extract, extracting by an ultrasonic-assisted extraction method at the material-liquid ratio of 1:20 and the extraction temperature of 30-45 ℃ for 0.5h, centrifuging and filtering after extraction, and collecting to obtain a first filtrate.
A first filtrate was taken and the filtrate was concentrated under reduced pressure to a volume of 1/5 which was the original volume to obtain a first concentrated suspension.
Obtaining a first concentrated suspension, and purifying the concentrated suspension through an adsorption resin to obtain a first eluent;
obtaining a first eluent, adding activated carbon for decoloring for 0.5h at the decoloring temperature of 40 ℃ to obtain a first decoloring solution;
and (3) obtaining a first destaining solution, carrying out reduced pressure concentration treatment on the first destaining solution to enable the volume of the first destaining solution to be concentrated to 1/7 of the original volume, and removing redundant ethanol to obtain a first concentrated solution.
Obtaining a first concentrated solution, and freeze-drying the first concentrated solution at-70-100 deg.C for 45 hr under vacuum pressure of 1.0Pa to obtain radix Sangusorbae extract.
10. A novel cosmetic preservative composition according to claim 9, wherein said extract of leaves of cotton rose is prepared by the steps of:
removing impurities from the dried roots of the cotton rose hibiscus leaves, crushing by using a plant crusher, and sieving by using a stainless steel mesh sieve of 40-80 meshes to obtain cotton rose hibiscus leaf powder;
obtaining Hibiscus mutabilis leaf powder, adding the Hibiscus mutabilis leaf powder into 85% ethanol water solution, and pre-treating with a low-temperature high-pressure homogenizer at a homogenizing temperature of 2-10 deg.C, a homogenizing pressure of 4-7MPa, and a homogenizing time of 30s to obtain a second extract;
and (3) obtaining a second extract, extracting by adopting an ultrasonic-assisted extraction method, wherein the material-liquid ratio is 1:25, the extraction temperature is 30-45 ℃, the extraction time is 0.75h, centrifuging and filtering after extraction, and collecting to obtain a second filtrate.
And (3) obtaining a second filtrate, and concentrating the second filtrate under reduced pressure to obtain 1/5 with the volume being the original volume so as to obtain a second concentrated suspension.
Obtaining a second concentrated suspension, and purifying the second concentrated suspension through adsorption resin to obtain an eluent;
obtaining a second eluent, adding activated carbon for decoloring for 0.4h at the decoloring temperature of 45 ℃ to obtain a second decoloring solution;
and (3) obtaining a second destaining solution, carrying out reduced pressure concentration treatment on the second destaining solution to enable the volume of the second destaining solution to be concentrated to 1/8 of the original volume, and removing redundant ethanol to obtain a second concentrated solution.
Obtaining a second concentrated solution, adjusting the pH value to 10.5 by adopting a sodium hydroxide solution, centrifuging to remove precipitates, then adjusting the pH value to 4.5 by adopting a hydrochloric acid solution, and centrifuging to obtain precipitates to obtain a precipitate solution;
collecting precipitate, washing with deionized water, and freeze drying at-70-100 deg.C for 60 hr under vacuum pressure of 3.5Pa to obtain folium Hibisci Mutabilis extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011076264.7A CN112137929A (en) | 2020-10-10 | 2020-10-10 | Novel cosmetic antiseptic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011076264.7A CN112137929A (en) | 2020-10-10 | 2020-10-10 | Novel cosmetic antiseptic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112137929A true CN112137929A (en) | 2020-12-29 |
Family
ID=73952794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011076264.7A Pending CN112137929A (en) | 2020-10-10 | 2020-10-10 | Novel cosmetic antiseptic composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112137929A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100918518B1 (en) * | 2009-04-13 | 2009-09-24 | 김정인 | Composition for pack improving quality of skin |
CN105250195A (en) * | 2015-10-14 | 2016-01-20 | 吴颖斯 | Plant compound preservative and acne removal skincare product |
CN108727957A (en) * | 2018-04-28 | 2018-11-02 | 杨芳 | A kind of anti-corrosive properties environment-friendly materials and preparation method thereof |
CN108852936A (en) * | 2018-08-07 | 2018-11-23 | 广东丸美生物技术股份有限公司 | Anticorrosive composite for cosmetics and preparation method thereof, purposes and cosmetics |
-
2020
- 2020-10-10 CN CN202011076264.7A patent/CN112137929A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100918518B1 (en) * | 2009-04-13 | 2009-09-24 | 김정인 | Composition for pack improving quality of skin |
CN105250195A (en) * | 2015-10-14 | 2016-01-20 | 吴颖斯 | Plant compound preservative and acne removal skincare product |
CN108727957A (en) * | 2018-04-28 | 2018-11-02 | 杨芳 | A kind of anti-corrosive properties environment-friendly materials and preparation method thereof |
CN108852936A (en) * | 2018-08-07 | 2018-11-23 | 广东丸美生物技术股份有限公司 | Anticorrosive composite for cosmetics and preparation method thereof, purposes and cosmetics |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Khare | Indian herbal remedies: rational western therapy, ayurvedic and other traditional usage, botany | |
KR101946236B1 (en) | Cosmetical composition with antimicrobial and antioxidant using natural plant extract and cosmetics comprising thereof | |
KR101952695B1 (en) | Composition having anti-wrinkle effects using the natural plant extract and cosmetic composition comprising the same | |
CN107308033A (en) | A kind of preparation method of olive fruits high-purity polyphenol and its application in cosmetics | |
JP2003192605A (en) | Lipase inhibitant | |
CN117243868B (en) | Camellia extract with soothing effect and preparation method and application thereof | |
KR101585922B1 (en) | Preparation method for natural shampoo composition comprising plant extracts and natural surfactant | |
KR20000032623A (en) | Extract of natural substances for cosmetic | |
CN102031116A (en) | New method for preparing rosemary natural antioxidant | |
CN113730479A (en) | Composition with health care function and preparation method and application thereof | |
KR101681258B1 (en) | Natural shampoo composition comprising plant extracts and natural surfactant | |
CN112891274A (en) | Prebiotics compound fermentation liquor for oil-control acne-removing cosmetics and preparation and application thereof | |
CN112076122A (en) | Novel broad-spectrum anticorrosive composition | |
CN109464317B (en) | Composition containing biota orientalis extract and preparation method and application thereof | |
CN114983902B (en) | Skin care composition containing pseudo-ginseng and preparation method thereof | |
KR20210096436A (en) | Shampoo Composition and manufacturing mehtod thereof | |
KR100937187B1 (en) | Method for the Preparation of Functional Cosmetics from Bokbunja Wine Processing Waste | |
KR20190025863A (en) | Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same | |
CN112137929A (en) | Novel cosmetic antiseptic composition | |
CN111184667B (en) | Composition with moistening and moisture-keeping and anti-allergy effects and preparation method thereof | |
KR102421800B1 (en) | Composition comprising fermented extract of Halophilic microorganism | |
KR20180138245A (en) | Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same | |
CN113081917A (en) | Female care solution containing hemp leaf extract and preparation method thereof | |
CN107875059B (en) | Composition with acne removing effect | |
CN112913953A (en) | Phlegm-reducing and heat-clearing health tea for middle-aged and old people and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201229 |